Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A28051 | 28286458 | Gastroenterol Hepatol (N Y) | Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis. | 2006 | Details |
| A28062 | 16540766 | J Clin Gastroenterol | Weight loss as a treatment for nonalcoholic fatty liver disease. | 2006 | Details |
| A28095 | 16447287 | Hepatology | Nonalcoholic fatty liver disease: from steatosis to cirrhosis. | 2006 | Details |
| A28100 | 16424622 | Indian J Gastroenterol | Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease. | 2006 | Details |
| A28107 | 16408478 | Nihon Koshu Eisei Zasshi | Metabolic syndrome from the view point of public health: with special reference to nonalcoholic fatty liver disease. | 2005 | Details |
| A28146 | 16265100 | Nat Clin Pract Gastroenterol Hepatol | Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. | 2005 | Details |
| A28153 | 16252575 | Ceylon Med J | Clinical, biochemical and histological characteristics of a Sri Lankan population of non-alcoholic steatohepatitis (NASH) patients. | 2005 | Details |
| A28179 | 16225470 | Aliment Pharmacol Ther | Review article: the treatment of fatty liver disease associated with the metabolic syndrome. | 2005 | Details |
| A28207 | 16140415 | J Hepatol | Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. | 2005 | Details |
| A28283 | 15811215 | Curr Med Res Opin | A review of the metabolic effects of sibutramine. | 2005 | Details |
| A28426 | 15046183 | Dig Liver Dis | Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? | 2004 | Details |
| A28431 | 15012772 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? | 2004 | Details |
| A28435 | 14969505 | Obes Rev | Hepatic steatosis in obese patients: clinical aspects and prognostic significance. | 2004 | Details |
| A28479 | 12739988 | Expert Opin Pharmacother | Current best treatment for non-alcoholic fatty liver disease. | 2003 | Details |
| A28493 | 12542595 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? | 2003 | Details |
| A28603 | 35256232 | Nutr Metab Cardiovasc Dis | Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial. | 2022 | Details |
| A28608 | 35243535 | Langenbecks Arch Surg | Expanding donor pool for live donor liver transplantation: utilization of donors with non-alcoholic steatohepatitis after optimization. | 2022 | Details |
| A28637 | 35212585 | Expert Rev Clin Immunol | Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives. | 2022 | Details |
| A28766 | 35036409 | Front Nutr | Relationship Between Fish Oil Use and Incidence of Primary Liver Cancer: Findings From a Population-Based Prospective Cohort Study. | 2021 | Details |
| A28944 | 34790547 | Endosc Int Open | Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study. | 2021 | Details |
| A28967 | 34765839 | VideoGIE | Effects of endoscopic gastric plication on portal pressure gradient in a patient with nonalcoholic steatohepatitis cirrhosis. | 2021 | Details |
| A28984 | 34740336 | BMC Public Health | The significant places of African American adults and their perceived influence on cardiovascular disease risk behaviors. | 2021 | Details |
| A29011 | 34710147 | PLoS One | A systematic review of interventions to promote physical activity in six Gulf countries. | 2021 | Details |
| A29546 | 33903842 | Cureus | Clinical Management of Nonalcoholic Steatohepatitis (NASH) With the Use of Thiazolidinediones and the Additive Effect of Thiazolidinediones and a GLP-1 Agonist: Case Series. | 2021 | Details |
| A29736 | 33604255 | J Clin Transl Hepatol | New Drugs on the Block-Emerging Treatments for Nonalcoholic Steatohepatitis. | 2020 | Details |
| A29803 | 33490302 | ACG Case Rep J | Intragastric Balloon Improves Steatohepatitis and Fibrosis. | 2021 | Details |
| A29933 | 33251276 | Visc Med | Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis. | 2020 | Details |
| A29991 | 33158472 | Best Pract Res Clin Gastroenterol | De novo and recurrent liver disease. | 2020 | Details |
| A30156 | 32882802 | Antioxidants (Basel) | Dietary Intervention Accelerates NASH Resolution Depending on Inflammatory Status with Minor Additive Effects on Hepatic Injury by Vitamin E Supplementation. | 2020 | Details |
| A30164 | 32875622 | J Food Biochem | Effect of cassava flour on the lipidic and redox profile of Wistar rats with dyslipidemia. | 2020 | Details |
| A30245 | 32742964 | Euroasian J Hepatogastroenterol | A Study on the Temporal Trends in the Etiology of Cirrhosis of Liver in Coastal Eastern Odisha. | 2022 | Details |
| A30445 | 32435609 | J Transl Int Med | Ketogenic, Hypocaloric Diet Improves Nonalcoholic Steatohepatitis. | 2020 | Details |
| A30880 | 31620539 | ACG Case Rep J | Intragastric Balloons: An Emerging Therapy for Nonalcoholic Steatohepatitis and Fibrosis? | 2019 | Details |
| A31229 | 31001415 | F1000Res | Recent advances in managing/understanding the metabolic syndrome. | 2019 | Details |
| A31304 | 30846912 | Gastroenterol Hepatol (N Y) | Pharmacologic Management of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A31536 | 30348753 | Pediatrics | Motivational Interviewing to Treat Adolescents With Obesity: A Meta-analysis. | 2018 | Details |
| A31571 | 30271738 | J Clin Transl Hepatol | Future Pharmacotherapy for Non-alcoholic Steatohepatitis (NASH): Review of Phase 2 and 3 Trials. | 2018 | Details |
| A31662 | 30084733 | J Neurotrauma | Dietary Green Tea Extract Prior to Spinal Cord Injury Prevents Hepatic Iron Overload but Does Not Improve Chronic Hepatic and Spinal Cord Pathology in Rats. | 2018 | Details |
| A32197 | 28981243 | Rev Med Brux | [Treatments of non-alcoholic steatohepatitis]. | 2019 | Details |
| A32715 | 27699065 | J Obes | Appetite Suppression and Antiobesity Effect of a Botanical Composition Composed of Morus alba, Yerba mate, and Magnolia officinalis. | 2016 | Details |
| A33136 | 26622825 | Oncol Lett | Clinicopathological characteristics of hepatitis B surface antigen-negative and hepatitis C antibody-negative hepatocellular carcinoma. | 2015 | Details |
| A33463 | 25943712 | Hepatol Res | Morbidly obese patient with non-alcoholic steatohepatitis-related cirrhosis who died from sepsis caused by dental infection of Porphyromonas gingivalis: A case report. | 2015 | Details |
| A33572 | 25681782 | Gynecol Oncol | Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application. | 2015 | Details |
| A33586 | 25646885 | J Hepatol | Clinical trial watch: reports from the AASLD Liver Meeting®, Boston, November 2014. | 2015 | Details |
| A33688 | 25411525 | J Clin Biochem Nutr | Questionnaire survey on lifestyle of patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A34156 | 26202298 | Hepatol Int | Pharmacological agents for nonalcoholic steatohepatitis. | 2013 | Details |
| A34203 | 24126564 | Nat Rev Gastroenterol Hepatol | Pharmacological agents for NASH. | 2013 | Details |
| A34478 | 23362564 | Bull Soc Sci Med Grand Duche Luxemb | Risk factors and disease prevalence in 3331 personal check-ups performed in preventive medicine between 2006 and 2011. cross-sectional and follow-up study. | 2012 | Details |
| A35029 | 21922031 | Therap Adv Gastroenterol | Glitazones for human nonalcoholic steatohepatitis. | 2011 | Details |
| A35111 | 21711428 | Hepatol Res | Pharmacological therapy for non-alcoholic steatohepatitis: How efficient are thiazolidinediones? | 2011 | Details |
| A35159 | 21575813 | J Adolesc Health | The delivery of behavioral sleep medicine to college students. | 2010 | Details |
| A35727 | 19827166 | Hepatology | Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. | 2010 | Details |
| A35731 | 19818311 | Clin Liver Dis | Lifestyle modification as the primary treatment of NASH. | 2009 | Details |
| A35864 | 19540686 | Gastroenterol Clin Biol | [Nonalcoholic fatty liver disease: 30 years research changed NASH]. | 2009 | Details |
| A35897 | 19473432 | Hepatol Res | Treatment of nonalcoholic steatohepatitis with colestimide. | 2009 | Details |
| A35964 | 19318980 | J Clin Gastroenterol | Thiazolidinediones for the treatment in NASH: sustained benefit after drug discontinuation? | 2009 | Details |
| A36893 | 16988759 | J Gastroenterol | Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature. | 2006 | Details |
| A37879 | 12883485 | Hepatology | Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. | 2003 | Details |
| A37942 | 12717402 | Hepatology | Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. | 2003 | Details |
| A38688 | 10553416 | Gan To Kagaku Ryoho | [Early detection and prevention of cancers in various therapeutic areas. Discussion]. | 1999 | Details |
| A42223 | 35170516 | Chin Med J (Engl) | Association between sex hormone-binding globulin and kidney function in men: results from the SPECT-China study. | 2022 | Details |
| A42249 | 35101891 | J Immunol | Methionine- and Choline-Deficient Diet Identifies an Essential Role for DNA Methylation in Plasmacytoid Dendritic Cell Biology. | 2022 | Details |
| A42282 | 34995404 | Liver Int | Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
| A42314 | 34897733 | JPEN J Parenter Enteral Nutr | Case presentation and panel discussion: Cardiometabolic risk mitigation. | 2021 | Details |
| A42387 | 34699206 | J Nat Prod | Hypocholesterolemic Efficacy of Secoisolariciresinol Diglucoside and Its Polymer in Rat. | 2021 | Details |
| A42404 | 34629818 | World J Gastroenterol | Liver disease in the era of COVID-19: Is the worst yet to come? | 2021 | Details |
| A42448 | 34509395 | Dig Liver Dis | Genes and lifestyle: Which of the two is more relevant in driving NAFLD progression? | 2021 | Details |
| A42471 | 34447810 | World J Clin Cases | Nonalcoholic fatty pancreas disease: An emerging clinical challenge. | 2021 | Details |
| A42547 | 34185279 | Front Med | Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial. | 2021 | Details |
| A42553 | 34172646 | Transplantation | Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients. | 2022 | Details |
| A42599 | 34058408 | Clin Gastroenterol Hepatol | Sugar-sweetened Beverages Are Associated With Increased Liver Stiffness and Steatosis Among Apparently Healthy Adults in the United States. | 2021 | Details |
| A42637 | 33939148 | Dig Dis Sci | Time to Step It Up: Mobile Health Intervention for Lifestyle Modification in Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42658 | 33868663 | Clin Liver Dis (Hoboken) | Lifestyle Intervention as the Primary Treatment for Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42671 | 33833375 | Sci Rep | Author Correction: Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects. | 2021 | Details |
| A42736 | 33604315 | J Hepatocell Carcinoma | Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes. | 2021 | Details |
| A42749 | 33586126 | Am J Clin Dermatol | Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges. | 2021 | Details |
| A42766 | 33535476 | Foods | Protection of Fatty Liver by the Intake of Fermented Soybean Paste, Miso, and Its Pre-Fermented Mixture. | 2021 | Details |
| A42782 | 33489993 | Can J Gastroenterol Hepatol | Diet and Lifestyle in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A42875 | 33247713 | Endocr Rev | Metabolic Consequences of Solid Organ Transplantation. | 2021 | Details |
| A42921 | 33088502 | Arch Public Health | Eating quickly is associated with a low aspartate aminotransferase to alanine aminotransferase ratio in middle-aged adults: a large-scale cross-sectional survey in Japan. | 2020 | Details |
| A42978 | 32899741 | Life (Basel) | Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study. | 2020 | Details |
| A43021 | 32795106 | Metab Syndr Relat Disord | Metabolic Syndrome in Children and Adolescents: Is There a Universally Accepted Definition? Does it Matter? | 2020 | Details |
| A43030 | 32763241 | Gastroenterology | Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis. | 2020 | Details |
| A43166 | 32389909 | Nihon Shokakibyo Gakkai Zasshi | [Lifestyle-related fatty liver disease]. | 2020 | Details |
| A43171 | 32378399 | J Obes Metab Syndr | Current Long-Term Pharmacotherapies for the Management of Obesity. | 2020 | Details |
| A43184 | 32353369 | Gastroenterology | Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum. | 2020 | Details |
| A43316 | 31986920 | Expert Opin Investig Drugs | Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery. | 2020 | Details |
| A43347 | 31933385 | Expert Opin Investig Drugs | Effectiveness of lifestyle interventions in NAFLD (nonalcoholic fatty liver disease) - how are clinical trials affected? | 2020 | Details |
| A43352 | 31928362 | Eur J Prev Cardiol | The 'heart' of preventive cardiology: Lifestyle medicine for the treatment of cardiometabolic diseases. | 2020 | Details |
| A43361 | 31905423 | J Food Biochem | Dietary solutions to dyslipidemia: Milk protein-polysaccharide conjugates as liver biochemical enhancers. | 2020 | Details |
| A43419 | 31764586 | J Hypertens | Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient. | 2020 | Details |
| A43589 | 31341440 | Integr Med (Encinitas) | Barrie Tan, PhD: Using Tocotrienols to Address Lifestyle and Metabolic Disease. | 2019 | Details |
| A43746 | 30984696 | J Family Med Prim Care | Questionnaire to assess adherence to diet and exercise advices for weight management in lifestyle-related diseases. | 2019 | Details |
| A43803 | 30837092 | J Hepatol | NAFLD and beneficial effects of lifestyle intervention: Defining the meat of the matter. | 2019 | Details |
| A43804 | 30837091 | J Hepatol | Reply to: "NAFLD and beneficial effects of lifestyle intervention: Defining the meat of the matter". | 2019 | Details |
| A43835 | 30761212 | Clin Liver Dis (Hoboken) | An Update on the Pharmacological Treatment of Nonalcoholic Fatty Liver Disease: Beyond Lifestyle Modifications. | 2018 | Details |
| A43854 | 30677262 | Obesity (Silver Spring) | Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity. | 2019 | Details |
| A43939 | 30403316 | J Intern Med | Precision medicine in type 2 diabetes. | 2018 | Details |
| A44001 | 30174510 | Saudi J Biol Sci | Effects of a medicinal plant Macrotyloma uniflorum (Lam.) Verdc.formulation (MUF) on obesity-associated oxidative stress-induced liver injury. | 2018 | Details |
| A44020 | 30135268 | Hong Kong Med J | Lifestyle intervention in obese Chinese adolescents with non-alcoholic fatty liver disease: a randomised controlled study. | 2018 | Details |